Vi

Vi is a health-enterprise AI company that sells a productized orchestration layer to healthcare organisations, biopharma firms and wellness businesses. Its principal product, the Vi Platform, integrates as a transparent AI layer designed to convert customer data into measurable patient and operational returns; the company claims a 4X return on investment. Technical work spans AI orchestration, healthcare data analytics, clinical-trial acceleration and data security and anonymisation. It operates in the United States.

The scale of that work is considerable. Vi reports more than $190m in research and development investment, 188m members served daily and more than 190m patients supported in healthier lifestyles. It says the platform has generated over $12bn in value for enterprise clients and accelerated the development of more than 35 life-changing drugs. Its anonymised datasets cover 96% of U.S. households.

Reported outcomes by sector include operational cost reductions of up to 50% for hospitals, a 76% acceleration in clinical trial timelines, an 87% improvement in wellness member enrollment and 4X ROI delivered. The verticals served include hospitals, biopharma and pharmaceuticals, drug development, oncology, pediatric epilepsy, diabetes and wellness.

Vi traces its origins to aerospace innovation and describes its mission as preventing silent system failures. Its stated operating principles emphasise transparency in AI and rigorous data security standards.